ReviewPublished 12 October 2026Multi-omics insights into immune dysregulation and candidate biological programs in kawasaki disease: toward precision immunomodulationYun Han · Jiaying Liu · Chengxu Song · Li Fu · Yu Gu · Yu Zeng · Zhenzhuang ZouFrontiers in Pediatricsdoi 10.3389/fped.2026.1960681
ReviewPublished 9 October 2026Treatment of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): acute attacks, relapse prevention, and symptomatic careJoão Vitor Mahler · Marina Vilardo · Guilherme Diogo Silva · Anastasia Vishnevetsky · Philippe-Antoine Bilodeau · Michael Levy · Marcelo MatielloFrontiers in Neurologydoi 10.3389/fneur.2026.1965135
ReviewPublished 9 October 2026Polyclonal IgG therapy in neurologic and neuromuscular disease: mechanisms of action and insights from newer therapiesMel BergerFrontiers in Neurologydoi 10.3389/fneur.2026.1819474
Mini ReviewPublished 6 October 2026Immunoglobulin replacement therapy in hematologic malignancy–associated secondary immunodeficiency: roles of SCIG and IVIGErika Seaquist · Anna Majapuro-Hirvonen · Rashelle Van Wagoner · Brent RutlandFrontiers in Hematologydoi 10.3389/frhem.2026.1904290
PerspectivePublished 1 October 2026Beyond the embryo: reframing recurrent implantation failure through immunopriming and endometrial immune dysregulationJayesh AminFrontiers in Reproductive Healthdoi 10.3389/frph.2026.1892030
Case ReportPublished 5 August 2026Case Report: Sickle cell anemia with complex alloimmunizationHenry Zou · Akram Alnounou · Tessa Kravchenko · Morgan Smeltzer · Cameron SchaecherFrontiers in Hematologydoi 10.3389/frhem.2026.1870201
Mini ReviewPublished 4 February 2026The urgent need for randomized controlled trials in pregnant women with antiphospholipid antibodies—protecting women through researchChristine Graversgaard Adams · Jullie Rudnicki · Berit Fabricius Petersen · Søren Jacobsen · Karen SchreiberFrontiers in Lupusdoi 10.3389/flupu.2026.1747204
